Anthony Antonucci signed Let Third Parties Debate: Lower the Polling Limit Requirement 2017-03-13 13:13:52 -0700GOAL: 765 signatures
For every 1,000 signatures, NationofChange will send a letter to the Commission on Presidential Debates, demanding that they lower their polling limit requirement so that we can hear from alternative political parties.
Our election system is broken. More than ever this election cycle voters are calling for more attention to third party candidates.
Currently, the Commission on Presidential Debates caters to the simple two party system, not allowing any candidates that poll under 15% to be a part of the debates. This does nothing but further the Democrat-Republican two party system and cut off Americans from hearing from alternate political views that don’t fall neatly into this political dichotomy.
Help us tell the Commission to lower its polling requirement so that other presidential candidates like Jill Stein can participate in nationally televised debates in the 2016 election and in the future.
Although multiple lawsuits have been filed the 15% policy, none of succeeded. How are millions of Americans going to hear from alternative candidates and raise them above a 15% rate if they don’t receive coverage and aren’t allowed to participate in national debates?
Please sign the petition and tell the Commission on Presidential Debates to lower their polling limit requirement so that we can hear from alternative political parties.
GOAL: 1,625 signatures
For every 1000 signatures, NationofChange will send a letter to Congress asking them to draft legislation that will provide funding and political help to prevent the extinction of giraffes.
[Update 3/16/17: We have sent the first letter to Congress with 1,000+ of your signatures. We will continue to send letters every 1,000 signatures. Thank you!]
Over the past 30 years, the giraffe population has dropped nearly 40%. With illegal hunting, habitat loss and environmental changes these mammals are being slowly pushed to extinction.
This decrease in giraffe population will continue until we do something to stop it. With funding and political help, these animals could be preserved. There is currently no legislation to help prevent this extinction.
“Whilst giraffes are commonly seen on safari, in the media and in zoos, people – including conservationists – are unaware that these majestic animals are undergoing a silent extinction,” said Julian Fennessy, co-chair of the IUCN’s giraffe and okapi specialist group. “It is timely that we stick our neck out for the giraffe before it is too late,” he said.
Sign this petition and help us tell Congress that the people want the protection of giraffes put into place.
Anthony Antonucci signed Tell Congress to Regulate Prescription Drug Prices 2017-01-13 13:04:17 -0800Very disappointed in the Democraps that voted against it. Especially Cory BookerGOAL: 2,376 signatures
For every 1000 signatures, NationofChange will send a letter to Congress, demanding that they pass legislation to regulate prescription drug prices and end price gouging.
[Update: We have surpassed 2000 signatures! NationofChange is sending a letter to Congress with your signatures attached, asking them to regulate prescription drug prices. We will continue to send letters for every 1000 signatures.]
Americans pay, by far, the highest prices for prescription drugs in the entire world.
Access to health care is a human right, and that should include affordable prescription drugs. Yet we have companies like Mylan, Turing Pharmaceuticals, and Ariad Pharmaceuticals that love to hike drug prices up. This means that many life saving drugs have become unaffordable for the average American family.
Last year, the former CEO of Turing Pharmaceuticals raised the price of an AIDS drug from $13.50 per pill to $750.00 — overnight.
Prices for drugs overall have increased more than tenfold between the year 2000 and today. The average price of cancer drugs is increasing by over $8,000 a year.
It is time for Congress to pass legislation to regulate pharmaceutical drug prices and end price gouging. This should also include things such as allowing Medicare to negotiate drug prices, allowing the importation of cancer drugs across U.S. borders for personal use, legislation that prevents drug companies from delaying access to generic drugs and extending the life of drug patents, and creating an FDA approval group or mechanism that can estimate and propose a fair price for new treatments.